Human Genome Epidemiology Literature Finder
Records 1 - 13 (of 13 Records) |
Query Trace: SMYD3[original query] |
---|
A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers. Nature genetics 2005 Oct 37 (10): 1104-7. Tsuge Masataka, Hamamoto Ryuji, Silva Fabio Pittella, Ohnishi Yozo, Chayama Kazuaki, Kamatani Naoyuki, Furukawa Yoichi, Nakamura Yusu |
Variable number of tandem repeats polymorphism in the SMYD3 promoter region and the risk of familial breast cancer. International journal of cancer 2005 12 118 (11): 2917-8. Frank Bernd, Hemminki Kari, Wappenschmidt Barbara, Klaes Rüdiger, Meindl Alfons, Schmutzler Rita K, Bugert Peter, Untch Michael, Bartram Claus R, Burwinkel Barba |
SMYD3 tandem repeats polymorphism is not associated with the occurrence and metastasis of hepatocellular carcinoma in a Chinese population. Experimental oncology 2007 Mar 29 (1): 71-3. Wang X Q, Miao X, Cai Q, Garcia-Barcelo M M, Fan S |
Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking. Cancer science 2008 Apr 99 (4): 787-91. Wang Haijian, Liu Yang, Tan Wen, Zhang Yang, Zhao Naiqing, Jiang Yan, Lin Chengzhao, Hao Bingtao, Zhao Dan, Qian Ji, Lu Daru, Jin Li, Wei Qingyi, Lin Dongxin, He Fuc |
SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer. Medical science monitor : international medical journal of experimental and clinical research 2016 Dec 22 5131-5140. Liu Ting-Ting, Xu Hui, Gao Wei-Ping, Zhang Shu-Xiang, Zhou Xu-Hong, Tang Juan, Liu Qiong- |
Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis. Bioscience reports 2017 Oct . Ma Shao-Jun, Liu Yan-Mei, Zhang Yue-Lang, Chen Ming-Wei, Cao W |
Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus.
Arthritis research & therapy 2018 May 20 (1): 100. Julià Antonio, López-Longo Francisco Javier, Pérez Venegas José J, Bonàs-Guarch Silvia, Olivé Àlex, Andreu José Luís, Aguirre-Zamorano Mª Ángeles, Vela Paloma, Nolla Joan M, de la Fuente José Luís Marenco, Zea Antonio, Pego-Reigosa José María, Freire Mercedes, Díez Elvira, Rodríguez-Almaraz Esther, Carreira Patricia, Blanco Ricardo, Taboada Víctor Martínez, López-Lasanta María, Corbeto Mireia López, Mercader Josep M, Torrents David, Absher Devin, Marsal Sara, Fernández-Nebro Anton |
The SMYD3 VNTR 3/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population. Pathology, research and practice 2018 Apr . Li Rui-Dong, Tang Yan-Hua, Wang Hui-Li, Yang Dong, Sun Li-Jun, Li W |
Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: A genotype-phenotype study. Gene 2019 12 728 144281. Al-Eitan Laith N, Rababa'h Doaa |
Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma. Scientific reports 2020 Feb 10 (1): 2797. Binh Mai Thanh, Hoan Nghiem Xuan, Giang Dao Phuong, Tong Hoang Van, Bock C-Thomas, Wedemeyer Heiner, Toan Nguyen Linh, Bang Mai Hong, Kremsner Peter G, Meyer Christian G, Song Le Huu, Velavan Thirumalaisamy |
Comprehensive Analysis of the Value of SMYD Family Members in the Prognosis and Immune Infiltration of Malignant Digestive System Tumors. Frontiers in genetics 2021 8 12 699910. Liu Donghui, Wang Xuyao, Shi Enhong, Wang Liru, Nie Minghao, Li Long, Jiang Qingxin, Kong Pengyu, Shi Shuai, Wang Chao, Yan Sen, Qin Zhihui, Zhao Shua |
Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma. Canadian journal of gastroenterology & hepatology 2021 2021 9990305. Sun Wei, Zhang Yongchao, Liu Bozhi, Duan Youjia, Li Wei, Chen Jinglo |
KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations. American journal of cancer research 2021 1 10 (12): 4464-4475. Zhang Xiaoshan, Zhang Ran, Chen Huiqin, Wang Li, Ren Chenghui, Pataer Apar, Wu Shuhong, Meng Qing H, Ha Min Jin, Morris Jeffrey, Xi Yuanxin, Wang Jing, Zhang Jianhua, Gibbons Don L, Heymach John V, Meric-Bernstam Funda, Minna John, Swisher Stephen G, Roth Jack A, Fang Binglia |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: